1. Alteration of Gastric Functions and Candidate Genes Associated With Weight Reduction in Response to Sibutramine 
Maria I. Vazquez Roque, Michael Camilleri, Matthew M. Clark, Debra A. TePoel, Michael D. Jensen, Karen M. Graszer, Sarah A. Kalsy, Duane D. Burton, Kari L. Baxter, Alan R. Zinsmeister 
Clinical Gastroenterology and Hepatology 
Volume 5, Issue 7, Pages (July 2007)
DOI: /j.cgh
Copyright © 2007 AGA Institute Terms and Conditions

2. Figure 1
Trial flow.
Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh )
Copyright © 2007 AGA Institute Terms and Conditions

3. Figure 2
Gastric emptying of solids and liquids in obese or overweight individuals treated with placebo or sibutramine.
Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh )
Copyright © 2007 AGA Institute Terms and Conditions

4. Figure 3
Change in body weight in overweight and obese males and females treated with placebo and sibutramine (A). Note the overall significant effects of sibutramine on weight loss are most clearly demonstrable in obese females. Changes in gastric emptying of solids (B) and liquids (C) in overweight and obese males and females treated with placebo and sibutramine. Note that overall significant effects of sibutramine on gastric emptying are most clearly demonstrable in obese females and overweight males.
Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh )
Copyright © 2007 AGA Institute Terms and Conditions